U.S., Aug. 9 -- ClinicalTrials.gov registry received information related to the study (NCT07111468) titled 'Clinical Trial to Evaluate the Efficacy and Safety of YHP2401 Compared to YHR2402 and YHR2403 for Acute Bronchitis' on Aug. 01.
Brief Summary: A Multicenter, Randomized, Double-blind, Parallel, Active-controlled, Superiority, Phase III Clinical Trial to Evaluate the Efficacy and Safety of YHP2401 Compared to YHR2402 and YHR2403 for Acute Bronchitis
Study Start Date: Oct. 17
Study Type: INTERVENTIONAL
Condition:
Acute Bronchitis
Intervention:
DRUG: YHP2401
Total 7 days of treatment and The daily dose is tid.(YHP2401 + Placebo of YHR2402 + Placebo of YHR2403)
DRUG: YHR2402
Total 7 days of treatment and The daily dose is tid.(P...